Safety and Efficacy of Bisphosphonates Beyond 24 Months in Cancer Patients

Abstract

Prolonged treatment with the potent bisphosphonates pamidronate and zoledronic acid seems to be well tolerated and should be studied in prospective, randomized studies to document prolonged skeletal efficacy.